Clinic marketing in Saudi Arabia differs from the UAE in three ways that matter: the audience is overwhelmingly resident rather than transient, Snapchat carries far more weight than it does in Dubai, and promotional material for medical devices needs SFDA approval before it runs. The structural discipline transfers. The channel mix and the compliance path do not.
The short version
- Saudi clinic audiences are resident, so the tourist targeting problem that dominates Dubai barely applies.
- Snapchat is a primary channel in Saudi, not an afterthought. Treating it as one is a real disadvantage.
- SFDA approval applies to medical device promotional material. Build that into the timeline, not the retrospective.
- Arabic is the default language, not a translation exercise bolted onto an English campaign.
Where we stand on proof. Our clinic account results come from the UAE. We do not have a Saudi clinic account with the same depth of history, and we are not going to move a UAE number across the border and present it as a Saudi benchmark. Every Saudi market figure below is attributed to a named third party. Every performance figure is labelled as UAE.
How big is the Saudi aesthetics market?
Large and growing faster than most agencies have adjusted to. IMARC Group values the Saudi medical aesthetics market at USD 1,604 million in 2024, projected to reach USD 3,541 million by 2033 at a compound annual growth rate of 9.16%.
Mordor Intelligence puts the aesthetic devices segment alone at USD 212 million in 2025, rising to USD 436 million by 2031. Vision 2030 targets one million international health visitors a year by 2030, with injectables, laser resurfacing and body contouring named among the core offerings.
What that means practically is that competition for clinic patients in Riyadh and Jeddah is rising quickly, and the clinics establishing an advertising position now are doing so against a smaller field than they will face in two years.
What transfers from a UAE clinic account and what does not?
| Element | Transfers to Saudi? | Why |
|---|---|---|
| Funding campaigns to clear the learning phase | Yes | Platform mechanics are the same everywhere. Roughly 50 conversions a week per ad set. |
| One campaign per treatment | Yes | Structural, not cultural. |
| Price on the creative as a filter | Yes | Works on any audience with a price sensitive decision. |
| Cost per lead benchmarks | No | Different auction, different competition, different currency. Our figures are UAE only. |
| Home only location targeting | Less critical | Saudi clinic audiences are largely resident. This was a Dubai specific problem. |
| Channel mix | No | Snapchat carries far more weight in Saudi than it does in the UAE. |
| Compliance path | No | SFDA and MOH rules are their own regime, not a variation on DHA. |
Which channels should a Saudi clinic run?
Snapchat deserves genuine consideration as a primary channel rather than a secondary test, which is the opposite of how most UAE agencies approach it.
Snapchat penetration in Saudi Arabia is among the highest in the world, and the platform reaches age groups that overlap closely with aesthetic treatment buyers. A clinic that runs Meta and Google only, because that is what the agency is comfortable with, is choosing a narrower audience than the market offers.
Meta still matters. Instagram in particular carries the visual proof that aesthetic treatments depend on. TikTok has grown substantially. Google Search captures the demand that already exists, particularly for dental and dermatology terms people search by name.
The sequencing advice from the UAE still holds: run one channel properly before opening a second, because splitting a budget across three platforms usually leaves all three below the volume they need.
What are the advertising rules for clinics in Saudi Arabia?
Two things to build into your process rather than discover afterwards.
First, promotional material for medical devices requires SFDA approval before it is published. CMS Law sets out the framework, and the practical effect is a lead time on creative that clinics used to UAE timelines routinely underestimate.
Second, advertising content must comply with the Law of Printed Materials and Publication and the Audio-visual Media Law, which govern content standards broadly. Clinic operating licences themselves come through the Ministry of Health.
Treat the approval timeline as part of the campaign plan. A creative concept that cannot be approved is not a creative concept, it is a delay.
How should a Saudi clinic handle language?
Arabic first, as the primary campaign rather than a translated secondary one.
This is a real difference from Dubai, where English frequently carries the majority of clinic spend. In Saudi the default should be Arabic creative written for the market, not English creative run through translation.
If you do run both, give each language its own ad set and enough budget to work. We have seen a UAE account where an early Arabic test appeared to fail badly, producing leads at AED 282 against AED 80 for English. The Arabic ad sets had received between a third and an eighth of the English budget and never reached the volume needed to leave the learning phase. The test measured funding, not language, and that mistake is easy to repeat in either market.
What should a Saudi clinic measure?
The same thing a UAE clinic should measure, and for the same reason: cost per booked consultation, reported separately for each treatment.
A single blended cost per lead across treatments is a broken measurement in any market, because treatment values differ by close to ten times. On the UAE account we have the longest history with, facial treatments produced leads at AED 21 to AED 54 while dermal filler ran from AED 66 to AED 202. Those are UAE numbers on a UAE account, quoted here to show the shape of the spread rather than as a Saudi benchmark.
Build your own targets from your own case values and close rates. That is the part of the method that travels perfectly.
A mistake we made: early on we quoted UAE performance benchmarks in a conversation about a Gulf market where we had no account history, because the numbers were ours and the question was reasonable. They were not applicable and we should have said so plainly. We now separate market data from account data explicitly in every document, and we label which country a figure came from in the same sentence as the figure.
If you are opening or scaling a clinic in Saudi Arabia and want a straight view of what transfers from the UAE and what does not, we are happy to have that conversation. Book a growth call. Or see how we run TikTok ads.
Frequently asked questions
Three main differences. Saudi clinic audiences are largely resident rather than transient, so the tourist targeting problem that dominates Dubai barely applies. Snapchat carries far more weight as a primary channel. And promotional material for medical devices requires SFDA approval before publication.
IMARC Group values Saudi medical aesthetics at USD 1,604 million in 2024, rising to USD 3,541 million by 2033 at 9.16% compound growth. Mordor Intelligence puts the aesthetic devices segment at USD 212 million in 2025, reaching USD 436 million by 2031.
We do not publish a Saudi figure because we do not have a Saudi clinic account with enough history to support one. Our published cost per lead benchmarks of AED 21 to AED 202 by treatment come from a UAE account and should not be read as Saudi numbers. Build your target from your own case values instead.
Promotional material for medical devices requires SFDA approval before publication, and advertising content must comply with the Law of Printed Materials and Publication and the Audio-visual Media Law. Build the approval lead time into the campaign plan rather than discovering it after a rejection.
Arabic first, written for the market rather than translated from English. If you run both languages, give each its own ad set with enough budget to reach roughly 50 conversions a week, otherwise an under-funded split produces a result that looks like a language failure and is actually a budget failure.